Clinical Trials on ALK Negative NSCLC
Total 438267 results
-
The First Affiliated Hospital with Nanjing Medical...RecruitingMetastatic NSCLC | Recurrent NSCLC | Advanced Non-Small Cell Squamous Lung CancerChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
OncoSec Medical IncorporatedCompletedER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Xuanzhu Biopharmaceutical Co., Ltd.Not yet recruiting
-
Regeneron PharmaceuticalsRecruiting
-
Spectrum Pharmaceuticals, IncTerminatedBreast Cancer | NSCLCUnited States
-
Samsung Medical CenterUnknownSquamous NSCLCKorea, Republic of
-
CelgeneCompletedBreast Cancer | Metastatic Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Breast Tumor | Cancer of the Breast | Triple-negative Metastatic Breast Cancer | Estrogen Receptor- Negative Breast Cancer | HER2- Negative Breast Cancer | Progesterone Receptor- Negative...United States, United Kingdom, Italy, Germany, Spain, Canada, Portugal, Australia, Austria, Greece, Brazil, France
-
SanofiUNC Lineberger Comprehensive Cancer CenterCompletedBrain Metastases | Estrogen Receptor Negative (ER-Negative) Breast Cancer | Progesterone Receptor Negative (PR-Negative) Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative (HER2-Negative) Breast CancerUnited States
-
ETOP IBCSG Partners FoundationTakedaRecruitingNSCLC, Stage III | ALK-rearrangementFrance, Spain, Italy, Poland, United Kingdom
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); MedImmune...TerminatedTriple Negative Breast Cancer | Triple Negative Breast Neoplasms | TNBC - Triple-Negative Breast Cancer | Triple-negative Breast CarcinomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Triple-negative Breast Carcinoma | Progesterone Receptor-negativeUnited States
-
Shanghai Kechow Pharma, Inc.Terminated
-
OHSU Knight Cancer InstituteOregon Health and Science University; Prospect Creek FoundationCompletedAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
University Hospital, Strasbourg, FranceNot yet recruiting
-
Shenzhen People's HospitalUnknownNSCLC | Apatinib | EGFR-TKIChina
-
Bristol-Myers SquibbCompletedLung Cancer | Non-small Cell Lung Cancer NSCLC | Small Cell Lung Cancer SCLCChina
-
Hatim HusainActive, not recruitingAdvanced NSCLCUnited States
-
BrightPath BiotherapeuticsTerminated
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Susan G. Komen Breast Cancer FoundationCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Metastatic Triple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Androgen Receptor PositiveUnited States
-
University of Maryland, BaltimoreSyndax PharmaceuticalsTerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Triple-negative Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast CancerUnited States
-
Sunshine Lake Pharma Co., Ltd.Not yet recruiting
-
Lung Cancer Group CologneTerminatedNSCLC | Lung Cancer | NSCLC Stage IV | Squamous Cell Lung Cancer | Pulmonary NeoplasmGermany
-
Qilu Hospital of Shandong UniversityUnknown
-
Indiana UniversityRecruitingNSCLC, Stage IIIUnited States
-
Microbio Co LtdRecruiting
-
Vastra Gotaland RegionAstraZenecaRecruitingNSCLC, Stage IFinland, Norway, Sweden
-
The Netherlands Cancer InstituteBristol-Myers SquibbTerminated
-
Intergroupe Francophone de Cancerologie ThoraciqueAmgenActive, not recruitingNsclc | KRAS P.G12CFrance
-
Fudan UniversityUnknown
-
The First Affiliated Hospital of Guangzhou Medical...Unknown
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
National Cancer Institute (NCI)GlaxoSmithKlineCompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
National Cancer Institute (NCI)TerminatedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
NeoTX Therapeutics Ltd.AstraZenecaActive, not recruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Ovarian Cancer | NSCLC | Prostate Cancer | Mesothelioma | Bladder Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Colorectal Cancer Metastatic | Head and Neck Squamous Cell Carcinoma | Urothelial Cancer | Cervical Squamous... and other conditionsIsrael
-
Swiss Group for Clinical Cancer ResearchNot yet recruitingTriple-negative Breast Cancer | TNBC - Triple-Negative Breast CancerSwitzerland
-
Newsoara Biopharma Co., Ltd.Not yet recruiting
-
Fujian Cancer HospitalNot yet recruiting
-
University Hospital, EssenRecruiting
-
Zhejiang Genfleet Therapeutics Co., Ltd.Active, not recruiting
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
Peking University Cancer Hospital & InstituteEnrolling by invitationLocally Advanced NSCLCChina
-
Sichuan UniversityInnovent Biologics (Suzhou) Co. Ltd.Completed
-
Shenzhen People's HospitalEnrolling by invitation
-
Yonsei UniversityWithdrawn
-
Kiang Wu HospitalCompleted
-
Agenus Inc.Terminated
-
AstraZenecaUnknownNSCLC Patient CharacteristicsSaudi Arabia